SOURCE: Cambridge Healthtech Institute

March 02, 2007 10:00 ET

Best of Show Awards Winners Named at the Fourteenth International Molecular Medicine Tri-Conference

Products Recognized in Five Categories by Vote of Conference Attendees

SAN FRANCISCO, CA -- (MARKET WIRE) -- March 2, 2007 --Cambridge Healthtech Institute's (CHI) Molecular Medicine Tri-Conference today announced that products from five companies were named Best of Show - New Product winners at a ceremony held here last night at the Moscone North Convention Center, San Francisco, CA. The winning companies include: BIOBASE Corporation, Biotrin International, Chemical Computing Group, GeneGo Inc., and Luminex Corporation.

One company was selected within five categories. The following winners were selected among 25 contenders who demonstrated new offerings on the show floor. Products were judged by conference attendees through a balloting process.

--  IT/Informatics
    BIOBASE Corporation:  BIOBASE ExPlain System
--  Preclinical Development
    Biotrin International: Early Biomarker
--  Medicinal Chemistry
    Chemical Computing Group: MOE 2006.08
--  Molecular Diagnostics
    Luminex Corporation: FlexmiR™ mircoRNA
--  Pathway Analysis
    GeneGo Inc.: MetaDrug 2.0
Best of Show Award winners received honorary signage, an awards logo, and an engraved award. They also will be featured in post-event coverage in CHI's newsletter; PharmaWeek,, and on the Cambridge Healthtech Institute's website,

About the Molecular Medicine Tri-Conference

The Molecular Medicine Tri-Conference is the largest annual West Coast biotech conference, bringing together 2,400 pharmaceutical and biotech leaders from over 38 countries. This year's event features over 200 presentations spanning 9 concurrent tracks focused throughout molecular medicine.

About Cambridge Healthtech Institute (CHI)

Cambridge Healthtech Institute's renowned conferences are the underpinning for all our other information resources. Each year, CHI organizes over 80 conferences. The company strives to develop quality programs that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business. Leading researchers and business experts from top pharmaceutical, biotech and academic organizations present their most current findings in a forum that features panel discussions and audience participation. Over the past 14 years, CHI has produced more than 600 conferences, attracting more than 50,000 attendees from around the world.

Contact Information

  • For more information, contact:
    Gina Bajenaru
    Director, Marketing Communications
    Bio-IT World, Inc.
    Email Contact

    Press Contact:
    Lisa Scimemi
    Cambridge Healthtech Institute
    Phone: 781-972-5419
    Email Contact